Nabil Laoudji

High-quality experimental data fuels biological discovery. Could an AI-enabled "autonomous lab" fundamentally increase the rate at which we generate it, and accelerate our progress toward cures for disease? That's the question I sat down to explore with Jason Kelly, CEO of Ginkgo Bioworks, for a deep-dive and tour of their 52-RAC lab in Boston's Seaport District. In our conversation we covered: → Ginkgo's recent collaboration with OpenAI on cell-free protein synthesis → U.S. Department of Energy's POTUS-backed Genesis Mission to accelerate AI for science → The evolution from cloud labs to truly autonomous labs → An on-the-floor look at Ginkgo's lab, including early challenges and creative workarounds If you're curious about frontier AI models meet the lab bench, check out the latest episode of the Discovery Engines Podcast. Watch or listen: 👀 YouTube: 🎧 Spotify: 🎧 Apple: